Harness technology advancements and biomolecular processes to research and develop technologies in genetics, agriculture, pharmaceuticals and vaccine development, environment and energy, forensic science, genetic counseling, and more to improve human health.
Building on a core of biology, chemistry, math, and liberal arts, the courses in this major are taught from a molecular bioscience perspective and are focused on the central genetic dogma of molecular biology. The curriculum explores the rapidly-expanding field of genetic engineering and almost unlimited potential that controlled genetic experiments hold for improving the quality of life. Specialized areas of interest include recombinant DNA, mammalian and plant tissue culture, and monoclonal antibody production.
Program facilities equipment
Students are exposed to nine teaching laboratories and 13 student/faculty research laboratories. Some of these labs include: NYS-DOH certified animal facility, Greenhouse and plant tissue culture facility, Confocal Microscopy Laboratory, Next Generation Sequencing platform
Program job titles reported
Research Assistant; Laboratory Technician; Clinical Lab Technologist; Research Associate; Biologist; Sales Representative; Technical Writer; Process Developer; Genetic Counselor; Forensic Analyst; Molecular Biologist; Medical and Clinical Laboratory Technician; Microbiologist; Agricultural and Food Science Technician
Program significant points
- RIT Biotechnology and Molecular Biosciences students have co-oped at pharmaceutical companies, academic research laboratories, Biotechnology companies, and National Laboratories.
- The Biotechnology and Molecular Science program prepares our graduates for post-secondary education, employment in biotech and research laboratories and medical school.
Select program hiring partners
ACM Global Laboratories, Cornell University, Fresenius Kabi, Integral Biosystems, Jabil, Johnson & Johnson Family of Companies, Litron Laboratories, MedMen, Polyclic Hospital San Marino, Regeneron Pharmaceuticals, Inc., The Jackson Laboratory, University of Rochester Medical Center, Vaccinex Inc.
|Outcome||% of Students|
|Full-time Graduate Study||48.00%|